Kirkland Advises Linden Capital Partners on Its Acquisition of Alcresta Therapeutics
March 19, 2024
March 19, 2024
CHICAGO, Illinois, March 19 -- Kirkland and Ellis, a law firm, issued the following news release:
Kirkland & Ellis represented Linden Capital Partners, a Chicago-based private equity firm focused exclusively on the healthcare industry, on its acquisition of Alcresta Therapeutics, Inc., a leader in commercializing novel enzyme-based products designed to address challenges faced by patients living with gastrointestinal disorders and rare diseases.
Read Linden's p . . .
Kirkland & Ellis represented Linden Capital Partners, a Chicago-based private equity firm focused exclusively on the healthcare industry, on its acquisition of Alcresta Therapeutics, Inc., a leader in commercializing novel enzyme-based products designed to address challenges faced by patients living with gastrointestinal disorders and rare diseases.
Read Linden's p . . .